CHB group:none

3 trials

Sponsors

The First Affiliated Hospital of Dalian Medical University, The first affiliated hospital of dalian medical university, Mengchao Hepatobiliary Hospital of Fujian Medical University; Fuzhou Infectious Hospital

Conditions

Chronic hepatitis B, Metabolic dysfunction-associated steatotic liver diseaseChronic hepatitis B, metabolic-associated fatty liver diseaseHBV-relative acute-on-chronic liver failure

Early Phase 1

The impact of hepatic steatosis on the clearance of hepatitis B virus and its bioinformatics analysis

Active, not recruitingChiCTR2300074064

The First Affiliated Hospital of Dalian Medical UniversityChronic hepatitis B, metabolic-associated fatty liver disease

Start: 2023-07-24Updated: 2023-07-30

Impact of MASLD on hepatitis B virus infection, clinical outcomes, and prognosis — A prospective, multi-center, real-world study (Sail Plan).

Active, not recruitingChiCTR2400092651

The first affiliated hospital of dalian medical universityChronic hepatitis B, Metabolic dysfunction-associated steatotic liver disease

Start: 2024-11-30Updated: 2024-12-02

Unknown Phase

The expression of soluble mannose recepor in severity and prognosis evaluation of HBV-relative acute-on-chronic liver failure

Active, not recruitingChiCTR-RPC-17010795

Mengchao Hepatobiliary Hospital of Fujian Medical University; Fuzhou Infectious HospitalHBV-relative acute-on-chronic liver failure

Start: 2017-05-01Updated: 2017-04-18